"Notre centre hospitalier dispose de spécialités médicales, chirurgicales, obstétricales et d'un plateau technique en constante évolution. Nous assurons un accueil et une prise en charge de qualité et de proximité 24h/24. Pour plus d'informations, veuillez nous contacter."

During the past decade, CH Eure-Seine conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Eure-Seine" #1 sponsor was "Centre Hospitalier Eure-Seine" with 3 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials sponsored, "Biotronik France" with 1 trials sponsored, "Centre Hospitalier Departemental Vendee" with 1 trials sponsored and "Centre Hospitalier Universitaire, Amiens" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Eure-Seine" #1 collaborator was "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Centre Henri Becquerel" with 1 trials as a collaborator, "Centre de traitement des données du Cancéropôle Nord-Ouest, Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator and "Institut National de la Santé et de la Recherche Médical (INSERM) 1086 (Pr Guy LAUNOY) Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "CH Eure-Seine" are "ALK Gene Mutation" (1 trials), "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" (1 trials), "Atrial Fibrillation" (1 trials), "Atrial Flutter" (1 trials) and "Atrial Tachycardia" (1 trials). Many other conditions were trialed in "CH Eure-Seine" in a lesser frequency.

Most popular intervention types in "CH Eure-Seine" are "Other" (4 trials), "Drug" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Discontinuation (or not initiation) of Immunosuppressive Therapy" (1 trials), "Lenalidomide" (1 trials), "Maintenance (or initiation) of immunosuppressive treatment: Imurel®, Mabthera®,Cellcept®, Cortancyl®" (1 trials), "Qualitative Interview" (1 trials) and "Questionnaires" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH Eure-Seine" are 10 trials for "All" genders.

Currently, there are NaN active trials in "CH Eure-Seine". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in CH Eure-Seine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CH Eure-Seine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

CH Eure-Seine has several departments that took part in Clinical trials: "Chi Eure Seine D Evreux; Nephrologie" - 2 trials, "Clinique Pasteur; Oncologie Medicale, Hematologie" - 2 trials